2019
DOI: 10.1002/clc.23168
|View full text |Cite
|
Sign up to set email alerts
|

Management of cardiogenic shock complicating acute myocardial infarction: A review

Abstract: Despite advances in percutaneous coronary interventions and their widespread use, mortality in patients presenting with acute myocardial infarction (MI) complicated by cardiogenic shock (CS) has remained very high, and treatment options are limited. Limited evidences exist, supporting many of the routinely used therapies in treating these patients. In the present article, we discuss CS complicating MI in general and an update on the currently available treatment options, including inotropes and vasopressor, co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
44
0
7

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 56 publications
(53 citation statements)
references
References 90 publications
1
44
0
7
Order By: Relevance
“…Furthermore, supportive drug treatments with inotropes and vasopressors bring no benefit to patients. Cardiologists hope that mechanical circulatory support will improve clinical outcomes in this population . The intra‐aortic balloon pump (IABP) becomes the first and most widely used device due to its ability to reduce afterload and improve coronary blood flow .…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Furthermore, supportive drug treatments with inotropes and vasopressors bring no benefit to patients. Cardiologists hope that mechanical circulatory support will improve clinical outcomes in this population . The intra‐aortic balloon pump (IABP) becomes the first and most widely used device due to its ability to reduce afterload and improve coronary blood flow .…”
Section: Introductionmentioning
confidence: 99%
“…Cardiologists hope that mechanical circulatory support will improve clinical outcomes in this population. 3,4 The intra-aortic balloon pump (IABP) becomes the first and most widely used device due to its ability to reduce afterload and improve coronary blood flow. [4][5][6][7] However, recent meta-analyses and the landmark randomized controlled trial did not show a beneficial effect of IABP in patients with AMI complicated by CS.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Ischemic heart disease (IHD) is a major cause of mortality and morbidity worldwide [1]. The estimated annual incidence of heart attack caused by myocardial infarction is 865 000 new and recurrent attacks, and the prevalence and mortality due to MI increases with age [2,3]. The prognosis of acute myocardial infarction (AMI) and ischemic cardiomyopathy (ICM) remains poor despite significant advances in medical therapy and revascularization strategies [4].…”
Section: Introductionmentioning
confidence: 99%
“…Infarct-related heart failure leads to an increase in the long-term comorbidity and mortality, which often counterbalances the benets which has been from the timely 5 reperfusion . A fraction of patients with STEMI presenting with normal hemodynamic parameters may deteriorate post the primary 6 PCI following they may develop CS . Previous studies have shown that around 50% of nal infarct myocardium is caused by the reperfusion 7 injury (RI) which occurs following PCI .…”
mentioning
confidence: 99%